Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 52

Cited In for PubMed (Select 18087271)

1.

Lung cancer screening: identifying the high risk cohort.

Marcus MW, Raji OY, Field JK.

J Thorac Dis. 2015 Apr;7(Suppl 2):S156-62. doi: 10.3978/j.issn.2072-1439.2015.04.19. Review.

2.

Clinical characteristics and prognosis of incidentally detected lung cancers.

Quadrelli S, Lyons G, Colt H, Chimondeguy D, Buero A.

Int J Surg Oncol. 2015;2015:287604. doi: 10.1155/2015/287604. Epub 2015 Feb 3.

3.

Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts.

Tammem├Ągi MC, Church TR, Hocking WG, Silvestri GA, Kvale PA, Riley TL, Commins J, Berg CD.

PLoS Med. 2014 Dec 2;11(12):e1001764. doi: 10.1371/journal.pmed.1001764. eCollection 2014 Dec.

4.

What characteristics of primary care and patients are associated with early death in patients with lung cancer in the UK?

O'Dowd EL, McKeever TM, Baldwin DR, Anwar S, Powell HA, Gibson JE, Iyen-Omofoman B, Hubbard RB.

Thorax. 2015 Feb;70(2):161-8. doi: 10.1136/thoraxjnl-2014-205692. Epub 2014 Oct 13.

5.

A review of cancer risk prediction models with genetic variants.

Wang X, Oldani MJ, Zhao X, Huang X, Qian D.

Cancer Inform. 2014 Sep 21;13(Suppl 2):19-28. doi: 10.4137/CIN.S13788. eCollection 2014. Review.

6.

Lung cancer screening: subsequent evidences of national lung screening trial.

Park YS.

Tuberc Respir Dis (Seoul). 2014 Aug;77(2):55-9. doi: 10.4046/trd.2014.77.2.55. Epub 2014 Aug 29. Review.

7.

Predicting lung cancer prior to surgical resection in patients with lung nodules.

Deppen SA, Blume JD, Aldrich MC, Fletcher SA, Massion PP, Walker RC, Chen HC, Speroff T, Degesys CA, Pinkerman R, Lambright ES, Nesbitt JC, Putnam JB Jr, Grogan EL.

J Thorac Oncol. 2014 Oct;9(10):1477-84. doi: 10.1097/JTO.0000000000000287.

PMID:
25170644
8.

Comparing benefits from many possible computed tomography lung cancer screening programs: extrapolating from the National Lung Screening Trial using comparative modeling.

McMahon PM, Meza R, Plevritis SK, Black WC, Tammemagi CM, Erdogan A, ten Haaf K, Hazelton W, Holford TR, Jeon J, Clarke L, Kong CY, Choi SE, Munshi VN, Han SS, van Rosmalen J, Pinsky PF, Moolgavkar S, de Koning HJ, Feuer EJ.

PLoS One. 2014 Jun 30;9(6):e99978. doi: 10.1371/journal.pone.0099978. eCollection 2014.

9.

Updates and controversies in the rapidly evolving field of lung cancer screening, early detection, and chemoprevention.

Kathuria H, Gesthalter Y, Spira A, Brody JS, Steiling K.

Cancers (Basel). 2014 May 16;6(2):1157-79. doi: 10.3390/cancers6021157.

10.

Cancer stem cell marker Musashi-1 rs2522137 genotype is associated with an increased risk of lung cancer.

Wang X, Hu JF, Tan Y, Cui J, Wang G, Mrsny RJ, Li W.

PLoS One. 2014 May 2;9(5):e95915. doi: 10.1371/journal.pone.0095915. eCollection 2014.

11.

Fifty years of tobacco carcinogenesis research: from mechanisms to early detection and prevention of lung cancer.

Hecht SS, Szabo E.

Cancer Prev Res (Phila). 2014 Jan;7(1):1-8. doi: 10.1158/1940-6207.CAPR-13-0371.

12.

Prediction of survival in resected non-small cell lung cancer using a protein expression-based risk model: implications for personalized chemoprevention and therapy.

Gold KA, Kim ES, Liu DD, Yuan P, Behrens C, Solis LM, Kadara H, Rice DC, Wistuba II, Swisher SG, Hofstetter WL, Lee JJ, Hong WK.

Clin Cancer Res. 2014 Apr 1;20(7):1946-54. doi: 10.1158/1078-0432.CCR-13-1959. Epub 2013 Dec 23.

13.

An ongoing case-control study to evaluate the NHS breast screening programme.

Massat NJ, Sasieni PD, Parmar D, Duffy SW.

BMC Cancer. 2013 Dec 13;13:596. doi: 10.1186/1471-2407-13-596.

14.

Lung cancer screening with low-dose computed tomography.

Chiles C.

Radiol Clin North Am. 2014 Jan;52(1):27-46. doi: 10.1016/j.rcl.2013.08.006.

15.

Screening for lung cancer with low-dose computed tomography: a review of current status.

Marshall HM, Bowman RV, Yang IA, Fong KM, Berg CD.

J Thorac Dis. 2013 Oct;5 Suppl 5:S524-39. doi: 10.3978/j.issn.2072-1439.2013.09.06. Review.

16.

Lung cancer screening: past, present and future.

Finigan JH, Kern JA.

Clin Chest Med. 2013 Sep;34(3):365-71. doi: 10.1016/j.ccm.2013.03.004. Epub 2013 Jul 23. Review.

17.

Bridging the clinical gaps: genetic, epigenetic and transcriptomic biomarkers for the early detection of lung cancer in the post-National Lung Screening Trial era.

Brothers JF, Hijazi K, Mascaux C, El-Zein RA, Spitz MR, Spira A.

BMC Med. 2013 Jul 19;11:168. doi: 10.1186/1741-7015-11-168. Review.

18.

Targeting of low-dose CT screening according to the risk of lung-cancer death.

Kovalchik SA, Tammemagi M, Berg CD, Caporaso NE, Riley TL, Korch M, Silvestri GA, Chaturvedi AK, Katki HA.

N Engl J Med. 2013 Jul 18;369(3):245-54. doi: 10.1056/NEJMoa1301851.

19.

Screening for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Detterbeck FC, Mazzone PJ, Naidich DP, Bach PB.

Chest. 2013 May;143(5 Suppl):e78S-92S. doi: 10.1378/chest.12-2350. Review.

20.

Chemoprevention of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Szabo E, Mao JT, Lam S, Reid ME, Keith RL.

Chest. 2013 May;143(5 Suppl):e40S-60S. doi: 10.1378/chest.12-2348. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk